Original news and analysis on international IP policy
With just over two weeks until the annual UN World Health Assembly begins, member states face a substantive agenda, including a sweeping reform programme, an innovative public health proposal, the global strategy for the prevention and control of noncommunicable diseases, a mechanism to fight poor quality medicines, and progress in pandemic influenza preparedness.
Once seen as a rising star on the global public health scene, the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria is in the throes of a top-down reform as it seeks to tailor its efforts to meet new realities, especially reductions in funding. While the new administration works to improve performance, a confidential document obtained by Intellectual Property Watch shows the terms on which departing staff is being asked to separate from the international organisation.
A recent book comes in time for the international policy debates coming to a head over access to medicines, intellectual property rights and public health in developing countries.
A copy of a key judgment by the High Court of Kenya last week that found a national anti-counterfeiting law was overly broad and might interfere with access to generic medicines is now available on Intellectual Property Watch.
The High Court of Kenya yesterday ruled that the country's 2008 Anti-Counterfeit Act was too broad and could interfere with the flow of legal generic medicines to patients, leading the UNAIDS organisation to issue a statement praising the decision. It also said intellectual property rights are not more important than life and health, according to UNAIDS.
An international convention on research and development for neglected diseases has never been so closely within reach. A World Health Organization expert group is recommending the implementation of a legally binding instrument to secure new sources of funding to spur health research in areas where the current system has failed.
Executive Director Ellen 't Hoen is departing the Medicines Patent Pool, the cutting edge UN spin-off project that works to lower prices on and stimulate new development of HIV medicines and other products through negotiating voluntary licence agreements. According to a release, 't Hoen has fulfilled the mission of guiding the organisation from a startup onto "firm footing" and has informed the Board that she will leave on 1 May.
A new treaty protocol against illicit trade in tobacco products struck today at the World Health Organization saw a late-stage decision to strip out references to “counterfeit” products from the text, according to sources.
The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.
The head of the West Africa region for the Global Fund to Fight AIDS, Tuberculosis and Malaria is the next in the line of departures under the organisation’s reforms. On the way out, he sent around a passionate farewell email calling for a dedication to values, and offering a small window on the wrenching transition taking place inside the international organisation.
World Health Organization Director-General Margaret Chan has issued a call for global support of Australia in defending its “plain packaging” tobacco law against an onslaught of legal challenges from the tobacco industry. The industry has cited trademark concerns as a top issue.
Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.